M1 KLINIKEN AG O.N./ DE000A0STSQ8 /
| 10/10/2024 11:49:26 AM | Chg. +0.450 | Volume | Bid11:49:26 AM | Ask11:49:32 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 16.850EUR | +2.74% | 9,476 Turnover: 157,828.800 |
16.600Bid Size: 276 | 16.850Ask Size: 96 | 325.1 mill.EUR | 3.02% | 30.65 |
Assets
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 5.5000 | 16 | 15.8000 | 15.3000 | 17.1770 | ||||||
| Intangible Assets | .3000 | .4000 | 4 | 60.4000 | 25.9710 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | 89.7170 | ||||||
| Inventories | 1.4000 | 1.5000 | 42.3000 | 35.2000 | 27.5860 | ||||||
| Accounts Receivable | 16.7000 | 22.2000 | 20.5000 | 16.3000 | 21.7730 | ||||||
| Cash and Cash Equivalents | 25.4000 | 9.1000 | 22 | 37.9000 | 35.1460 | ||||||
| Current Assets | 44.6000 | 59.3000 | 122.4000 | 110.2000 | 107.3060 | ||||||
| Total Assets | 69.6000 | 92.8000 | 188.7000 | 198.1000 | 197.0240 | ||||||
Liabilities
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | .9000 | 7.8000 | 15.8000 | 12.8000 | 19.2210 | ||||||
| Long-term debt | - | - | - | - | 3.1250 | ||||||
| Liabilities to Banks | .0800 | .2000 | 22.3000 | 14.8000 | - | ||||||
| Provisions | .7000 | 2.1000 | 3.9500 | 4.1600 | 4.3630 | ||||||
| Liabilities | 5.9000 | 24.6000 | 73.5000 | 58.2000 | 53.9740 | ||||||
| Share Capital | 17.5000 | 17.5000 | 19.6000 | 19.6000 | - | ||||||
| Total Equity | 63.7000 | 68.2000 | 115.3000 | 139.9000 | 95.5200 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 47.5300 | ||||||
| Total liabilities equity | 69.6000 | 92.8000 | 188.7000 | 198.1000 | 197.0240 | ||||||
Income Statement
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 65.2000 | 77.2000 | 159.6000 | 314.6000 | 285.2910 | ||||||
| Depreciation (total) | .7000 | 3.4000 | 4.5000 | 5.7000 | 6.0620 | ||||||
| Operating Result | 6.5000 | 7.9000 | 4.4000 | 12.1000 | 9.3470 | ||||||
| Interest Income | 1.6900 | -.2200 | -.4000 | -.2000 | -.1860 | ||||||
| Income Before Taxes | 8.1000 | 12.7000 | 8.8000 | 14.4000 | - | ||||||
| Income Taxes | 1.5000 | 3 | 1.4000 | 3.5000 | 3.1630 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 2.7520 | ||||||
| Net Income | 6.6000 | 9.7000 | 7.4000 | 10.9000 | 4.3170 | ||||||
Per Share
Cash Flow
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 2.9000 | -5.4000 | 9.5000 | 15.7000 | 20.7680 | ||||||
| Cash Flow from Investing Activities | -1.9000 | -3.3000 | 3.1000 | .2000 | -1.1160 | ||||||
| Cash Flow from Financing | 9.8000 | -7.6000 | .3000 | .5000 | -22.3670 | ||||||
| Decrease / Increase in Cash | 10.7000 | -16.3000 | 8.9000 | 19.9000 | - | ||||||
| Employees | 181 | 236 | 428 | 350 | 366 | ||||||
